These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34184543)

  • 1. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.
    Moayedi Y; Truby LK; Foroutan F; Han J; Guzman J; Angleitner P; Sabatino M; Felius J; VAN Zyl JS; Rodenas-Alesina E; Fan CP; Devore AD; Miller R; Potena L; Zuckermann A; Farrero M; Chih S; Farr M; Hall S; Ross HJ; Khush KK
    J Card Fail; 2024 Jun; 30(6):805-815. PubMed ID: 37907150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
    J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Outcome in Severe Left Ventricular Primary Graft Dysfunction Post Cardiac Transplantation Supported by Early Use of Extracorporeal Membrane Oxygenation.
    Connolly S; Granger E; Hayward C; Huang D; Kerr S; McCanny P; Buscher H
    Transplantation; 2020 Oct; 104(10):2189-2195. PubMed ID: 31895346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.
    Takeda K; Li B; Garan AR; Topkara VK; Han J; Colombo PC; Farr MA; Naka Y; Takayama H
    J Heart Lung Transplant; 2017 Jun; 36(6):650-656. PubMed ID: 28087104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK; Takeda K; Topkara VK; Takayama H; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death.
    Ayer A; Truby LK; Schroder JN; Casalinova S; Green CL; Bishawi MA; Bryner BS; Milano CA; Patel CB; Devore AD
    J Card Fail; 2023 Jan; 29(1):67-75. PubMed ID: 36351494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant.
    Jacob S; Lima B; Gonzalez-Stawinski GV; El-Sayed Ahmed MM; Patel PC; Belli EV; Makey IA; Thomas M; Landolfo K; Landolfo C; Leoni Moreno JC; Yip DS; Pham SM
    Clin Transplant; 2019 May; 33(5):e13538. PubMed ID: 30870577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation.
    Kawabori M; Mastroianni MA; Zhan Y; Chen FY; Rastegar H; Warner KG; Reich JA; Vest A; DeNofrio D; Couper GS
    J Artif Organs; 2020 Jun; 23(2):140-146. PubMed ID: 31713054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant.
    DeRoo SC; Takayama H; Nemeth S; Garan AR; Kurlansky P; Restaino S; Colombo P; Farr M; Naka Y; Takeda K
    J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1576-1584.e3. PubMed ID: 30948318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction.
    Kransdorf EP; Rushakoff JA; Han J; Benck L; Malinoski D; Emerson D; Catarino P; Rampolla R; Kobashigawa JA; Khush KK; Patel JK
    J Heart Lung Transplant; 2023 May; 42(5):617-626. PubMed ID: 36682894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant.
    Hulman M; Artemiou P; Ondrusek M; Hudec V; Gasparovic I; Bena M; Glonek I
    Interact Cardiovasc Thorac Surg; 2018 Aug; 27(2):229-233. PubMed ID: 29514222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation.
    Wright M; Takeda K; Mauro C; Jennings D; Kurlansky P; Han J; Truby L; Stein S; Topkara V; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M; Takayama H
    J Heart Lung Transplant; 2017 Nov; 36(11):1226-1233. PubMed ID: 28583372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PREDICTA: A Model to Predict Primary Graft Dysfunction After Adult Heart Transplantation in the United Kingdom.
    Avtaar Singh SS; DAS DE S; Rushton S; Berry C; Al-Attar N
    J Card Fail; 2019 Dec; 25(12):971-977. PubMed ID: 31330297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of controlled hypothermic preservation on outcomes following heart transplantation.
    D'Alessandro D; Schroder J; Meyer DM; Vidic A; Shudo Y; Silvestry S; Leacche M; Sciortino CM; Rodrigo ME; Pham SM; Copeland H; Jacobs JP; Kawabori M; Takeda K; Zuckermann A
    J Heart Lung Transplant; 2024 Jul; 43(7):1153-1161. PubMed ID: 38503386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    Buchan TA; Moayedi Y; Truby LK; Guyatt G; Posada JD; Ross HJ; Khush KK; Alba AC; Foroutan F
    J Heart Lung Transplant; 2021 Jul; 40(7):642-651. PubMed ID: 33947602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System.
    Lerman JB; Patel CB; Casalinova S; Nicoara A; Holley CL; Leacche M; Silvestry S; Zuckermann A; D'Alessandro DA; Milano CA; Schroder JN; DeVore AD
    Circ Heart Fail; 2024 May; 17(5):e010904. PubMed ID: 38602105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.
    Samano MN; Fernandes LM; Baranauskas JC; Correia AT; Afonso JE; Teixeira RH; Caramori ML; Pêgo-Fernandes PM; Jatene FB
    Transplant Proc; 2012 Oct; 44(8):2462-8. PubMed ID: 23026621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.